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Abstract: Diabetes is an important modifying factor of periodontitis, but its association with
peri-implant diseases has not been fully explored and the existing literature reports controversial
results. The aim of this retrospective study was to evaluate the influence of diabetes on peri-implantitis
and implant failure. Smoking status, history of periodontal disease, presence of diabetes, diabetes
type, therapy and glycaemia levels were collected in a total of 204 subjects treated with 929 implants,
with a mean follow-up time of 5.7 ± 3.82 years after loading. Odds ratio (OR) for diabetes as a direct
cause of peri-implantitis and implant failure were calculated, adjusted for smoking status and history
of periodontitis. Nineteen patients were diabetic and most of them presented a good control of the
disease at the time of surgery. The overall patient-level prevalence of peri-implantitis was 11.3%.
Among diabetic patients, one developed peri-implantitis, whereas one experienced multiple implant
failures. The calculated ORs, adjusted for smoking status and periodontitis, were not statistically
significant. The results revealed no association between diabetes and peri-implantitis or implant
failure coherently with the existing scientific literature. The actual influence of hyperglycemia on
implant failure is still uncertain and new studies with larger cohorts of patients are needed.
Keywords: dental implants; diabetes; hyperglycemia; implant failure; peri-implantitis
1. Introduction
In the last few decades, the scientific evidence on biofilm-related inflammatory peri-implant
diseases has substantially increased. Peri-implantitis, which leads to progressive marginal bone
loss around implants, represents the main cause of late implant failure. A new definition has been
settled for peri-implantitis in the World Workshop on Periodontology (WWP) in 2017 [1], where the
diagnosis of peri-implantitis required: (a) the presence of bleeding and/or suppuration on gentle
probing; (b) an increased probing depth compared to previous examinations (in the absence of previous
examination: PD ≥ 6 mm); (c) further bone loss as compared to the initial bone remodeling (in the
absence of previous examination: bone levels ≥3 mm apical of the most coronal portion of the
intraosseous part of the implant). The lack of a univocal definition in the past led to controversial
results, with reported prevalence rates ranging from 1.1% to 85% on the implant level [2] and from
0 to 39.7% on the patient level [3]. History of periodontitis and low hygiene levels are proven risk
factors for peri-implantitis, while the role of other factors, including smoking status and diabetes,
is still unclear. Diabetes mellitus (DM) comprises a group of metabolic disorders characterized by
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hyperglycemia, which is due to the impairment of insulin secretion and/or action. The incidence of
DM and its prevalence has been increasing significantly over the last few decades. The International
Diabetes Federation estimated 451 million cases of diabetes in 2017, which represent a global prevalence
of 8.4% and are expected to rise [4]. While diabetes has been proven as an important risk factor for
periodontitis, its association with peri-implant diseases has not been fully explored, and the existing
literature reports controversial results. Some hypotheses of how diabetes could interfere with implant
success have been formulated, and these include: the suppression of osteoblastic differentiation,
proliferation and activity, deficits in the healing process, and the alteration of the immune response [5].
The primary aim of this retrospective study was to evaluate the relationship between the presence
of diabetes and the occurrence of biological complications at the implant site, namely the development of
peri-implantitis and of post-operative complications; the secondary aim was to evaluate its association
with implant survival rate.
2. Materials and Methods
The clinical records of all subjects treated with implants during the period between 1 January 2005,
and 31 December 2018 in the Dental Clinic of the IRCCS Istituto Ortopedico Galeazzi (Milan, Italy) were
screened. The following inclusion criteria were adopted for clinical record selection: (a) 18-year-old or
older patients at the time of intervention; (b) patients who gave their written informed consent for the
use of their clinical records for research purposes; (c) patients whose implants present complete clinical
and radiographical records, including at least one radiograph per year and a report of complications.
Patients lost at follow-ups were excluded from the study.
2.1. Outcomes
The primary outcome was the correlation between the presence of diabetes and the development
of peri-implantitis. The secondary outcomes were: patient—and implant-level cumulative prevalence
of peri-implantitis, patient—and implant-level cumulative implant survival rate, and prevalence of
post-operative complications that occurred immediately after the surgical intervention.
2.2. Data Collection
The following parameters were collected: gender; age at the time of surgery; ASA score; presence
of systemic diseases, smoking status, history of periodontal disease, and presence of diabetes; in case
of diabetes, diabetes type, diabetes therapy at surgery, glycaemia levels, and glycated hemoglobin
(HbA1c) before surgery, glycosuria and leukocyte formula before surgery were also registered; implant
type and characteristics (width, length); prosthesis type (fixed partial dentures, full arch fixed dentures,
full arch removable dentures); date of diagnosis of peri-implantitis; date of implant loss/removal.
The diagnosis of diabetes was formulated according to the American Diabetes Association guidelines [6].
Peri-implantitis was defined as the presence of bleeding and/or suppuration on gentle probing, together
with at least 2 mm bone resorption, evaluated through the comparison of baseline and follow-up
periapical radiographs [7]. All the clinical and radiographic records were re-analyzed to verify the
diagnosis of peri-implantitis according to the most recent definition [1].
2.3. Statistical Analysis
The Shapiro–Wilk tests served to evaluate the normality of the distribution of the variables
considered. Descriptive statistics were provided by means of mean values and standard deviations for
normally distributed variables.
The cumulative survival rate was calculated by means of survival tables. The absolute patient-level
prevalence of peri-implantitis was calculated for diabetic and non-diabetic subjects. Correlation between
baseline parameters and outcomes was provided through the use of logistic regression. Odds ratio
(OR) for diabetes as a direct cause of peri-implantitis and implant failure were calculated, adjusted for
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smoking status, history of periodontitis, gender, age, ASA score, presence of systemic diseases, implant
type and characteristics, and prosthesis type) on survival curves. The level of significance was p < 0.05.
3. Results
A total of 204 patients and 929 implants were included. A wide range of implant systems were
used, but all of them presented an internal connection with a polygonal design. Among all included
subjects, 90 were males and 114 were females, the mean age at the time of surgery was 57.3 ± 13.7 years,
127 had a history of periodontitis, 50 were smokers, and 18 were former smokers. The mean follow-up
time was 5.7 ± 3.82 years, varying from 3 months to 15 years after loading. Nineteen patients were
diabetic, and most of them demonstrated a good control of the disease. Two subjects presented type 1
DM and were being treated with insulin, while seventeen presented type 2 DM; the details of their
therapy is specified in Table 1, together with the descriptive analysis of diabetes-related parameters.
Among the diabetic patients, seven received a full-arch implant-supported prosthesis, three received
an overdenture prosthesis, six fixed partial dentures, and seven were treated with multiple single
crowns; three patients were treated with both fixed partial dentures and single crowns, and one with
both an overdenture and a fixed partial prosthesis.
Table 1. Clinical parameters of diabetic patients (n = 19). Continuous variables are reported as
mean ± standard deviation (minimum; maximum). Discrete variables are reported as number of cases.
Parameter Values Before Surgery
Diabetes type Type 1: 2Type 2: 17
Diabetes therapy
Diet only: 5
Metformin: 7
Insulin: 3
Sulfonylureas (glimepiride): 1
Metformin + sulfonylureas (glimepiride, glibenclamide): 3
Metformin + pioglitazone + glicazide: 1
Glycemia at surgery (mg/dL) 127.63 ± 25.67 (91; 155)
Glycated haemoglobin at surgery (%) 6.40 ± 0.36 (5.9; 8.0)
Glycosuria (mg/dL) 0 ± 0 (0; 0)
Lymphocytes (109/L) 2.48 ± 0.72 (1.47; 3.43)
Neutrophiles (109/L) 4.19 ± 1.30 (2.40; 6.21)
A total of 23 cases of peri-implantitis (patient-level) were registered, representing an overall
prevalence of 11.3%. Only one diabetic patient (type 2) developed peri-implantitis (5.3%) whereas one
subject with type 1 diabetes experienced multiple implant failures due to a failure of osseointegration.
Figures 1 and 2 show radiographic evidence of peri-implantitis in one diabetic (Figure 1) and one
non-diabetic patient (Figure 2). Figures 1 and 2 show radiographic evidence of peri-implantitis in
one non-diabetic (Figure 1) and one diabetic patient (Figure 2). A clinical image of the same diabetic
patient is represented in Figure 3.
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Patient-level cumulative implant survival rate was 95.42% 10 years after surgery, which was 96.51%
and 94.74%, respectively, for diabetic and non-diabetic patients, without any significant difference.
None of the diabetic patients experienced post-operative complications.
The OR for diabetes as a cause of peri-implantitis, adjusted for smoking status and history of
periodontitis, was not statistically significant (OR = 0.47 (95% C.I. 0.06–3.76)). Similarly, the association
between diabetes and implant failure, adjusted for the same proven risk factor, resulted not significative
(OR = 1.23 (95% C.I. 0.11–13.30)). The results were adjusted for gender, age, ASA score, presence of
systemic diseases, implant type and characteristics, and prosthesis type: none of the above-mentioned
parameters were found to influence the development of peri-implantitis.
The small number of cases among diabetic patients prevented us from considering diabetes type
and therapy for statistical analysis.
4. Discussion
The association between diabetes and the status of peri-implant tissues has been explored
extensively in literature, with heterogenous and controversial results [8–10]. The results of our study
revealed no association between diabetes and the occurrence of peri-implantitis, finding an insignificant
OR in the examined cohort. Such results are coherent with those presented by Renvert et al. [11] who
did not find a significant OR between a history of type 2 diabetes and peri-implantitis in a cohort of
270 subjects followed-up over time. It must be noted that in the above-mentioned paper, the authors
adopted a definition of peri-implantitis that was different from ours, and that could, hypothetically,
be the cause of finding a higher prevalence of peri-implantitis. Conversely, Ferreira et al. [12] observed
that diabetic patients were more susceptible to develop peri-implantitis, reporting a peri-implantitis
prevalence of 24% in diabetic patients and 7% in non-diabetic patients. It must be noted, however, that
these results refer to diabetic patients regardless of their glycemic control. In fact, the authors found
a higher risk of peri-implantitis, with an adjusted OR of 1.9, for subjects with uncontrolled diabetes,
even though the latter was not clearly defined. Daubert et al. [13] also reported a relative risk of 4.1 for
peri-implantitis in diabetic patients; however, their study included only five diabetic patients, which
could have influenced the statistical analysis in both excess and defect. A meta-analysis published
by Monje et al. in 2017 [10] calculated that both the OR and RR (risk ratio) for peri-implantitis were
statistically higher in hyperglycemia than in normoglycemia; however, such meta-analysis could
not evaluate the impact of smoking and glycemic level because of the lack of information from the
included studies.
A relationship between the level of metabolic control of diabetes and peri-implantitis has
been suggested in the literature. Venza et al. [14] found that some clinical parameters, including
PD and radiographic bone loss, were significantly higher (p < 0.05) in poorly-controlled diabetic
patients (HBA1c ≥ 8%), as compared to well-controlled diabetic patients (HBA1c < 8%). The authors
thus suggested that a poor glycemic control may be involved in the modulation of periodontal
destruction and could have a correlation with the severity of peri-implantitis. On the other hand,
Gomez-Moreno et al. [15] found that higher HBA1c levels led to higher bone loss over 3 years after
implant placement, although this association was not statistically significant. The association between
elevated HbA1c levels and increased marginal bone loss had a statistically significant result in a
different prospective study by Aguilar-Salvatierra et al. [16]. However, in a recent meta-analysis of
seven prospective studies [17], Lagunov et al. observed that PD, BOP, and marginal bone loss showed
a significantly higher increase in type 2 DM patients as compared to healthy patients, after a period of
12 months, independently from the level of glycemic control.
Our study only included one poorly-controlled patient, undergoing multiple implant failures.
Therefore, no further analysis was possible regarding the development of peri-implantitis. In addition,
the patient presented HbA1c ≥ 8.0, but lower than 9%, which is considered as “moderately-controlled
diabetes” in some studies.
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Our study did not reveal any statistically significant association between diabetes and
post-operative complications, but this could also be due to the small size of the DM group.
As for implant survival rates, the present study did not find any association with diabetes. A recent
review published by Oliveira-Neto et al. in 2019 [5] came to the same conclusion, reporting that
diabetes did not affect implant survival rate in two meta-analyses of high methodological quality [18,19].
Chrcanovic et al. [18] analyzed a total of 604 subjects (49 diabetic, 555 non-diabetic) and reported
an RR of 1.07, while Moraschini and Barboza [19] analyzed a total of 2334 subjects (802 diabetic,
1532 non-diabetic), with an RR of 1.43 and 3.65 for type 1 and type 2 DM, respectively; it must be noted
that in all the included studies diabetes was under control at the time of the surgery.
A weakness of the present study is the wide range of follow-up times, which was almost 6 years on
average, representing a medium-term follow-up, but reached a minimum of 3 months after functional
loading. Such short follow-up time still allows the evaluation of post-operative and short-term
complications, but cannot account for a long-term analysis. However, all the diabetic patients but one
presented a follow-up of more than 1 year, reaching a maximum of 13 years.
Another limitation of the study is that more than one systemic disease can be found in the same
patient, resulting in a confounding factor. It must be noted that the only patient undergoing multiple
early failures also had cardiovascular disease.
One of the strengths of our study is the fact that glycemia levels and glycated hemoglobin at surgery
were recorded, which could allow the detection of the association between the level of compensation of
the disease and the occurrence of early complications. Although the small number of diabetic patients
prevented us from performing a specific and “powerful” statistical analysis, the registration and
analysis of these parameters are fundamental for further meta-analysis of similar studies. Moreover,
it should be noted that the only patient with poor glycemic control (HbA1c≥ 8.0%) experienced multiple
implant failure with a lack of osseointegration. Interestingly, some previous studies reported higher
rates of early implant failures in diabetic patients [20,21], and one prospective study by Ghiraldini et al.
observed that hyperglycemia negatively affected the implant osseointegration [22]. However, a recent
meta-analysis by Shi et al. [23] found no significative association between diabetes and implant failure
in patients with both good and poor metabolic control.
A possible limitation of our study could be that glycemia levels and HbA1c were not registered at
follow-up visits, preventing us from disclosing a possible association between glycaemia levels
in diabetic patients and long-term complications. Even though glycemia levels and HbA1c
measured immediately before surgery could be of great relevance in relations to early complications,
the subsequent changes in the level of metabolic compensation could be not easily controlled over
the years and may influence the onset of long-term biological complications. Hence, further studies
analyzing the association between glycemia levels before and after surgery, and the occurrence of
biological complications and implant failure, are needed.
It should be underlined that the definition of peri-implantitis proposed by Heitz-Mayfield et al.
in 2014 was used in this study, but all the included records were re-analyzed during data collection
and the cases of peri-implantitis were confirmed in light of the new definition settled in the WWP in
2017 [1].
5. Conclusions
The actual influence of DM and hyperglycemia on peri-implantitis and implant failure is still
uncertain and new studies on larger cohorts of patients are needed also taking into consideration
further parameters, such as HbA1c baseline and follow-up values, baseline and follow-up diabetic
therapy, and duration of diabetes. Future studies are needed to investigate the relationship between
the long-term changes in glycemia and HbA1c levels and the health status of peri-implant tissues.
Monitoring the main parameters of glycemic control is desirable not only for research purposes, but
also for clinicians, since poor metabolic control may lead to complications such as increased risk of
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infections. Within the limitations of the present study, our results confirm that implant therapy in
diabetic patients with good glycemic control should be considered a safe and viable treatment option.
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